Urine Metabolites Enable Fast Detection of COVID-19 Using Mass Spectrometry.
Ontology highlight
ABSTRACT: The COVID-19 pandemic boosted the development of diagnostic tests to meet patient needs and provide accurate, sensitive, and fast disease detection. Despite rapid advancements, limitations related to turnaround time, varying performance metrics due to different sampling sites, illness duration, co-infections, and the need for particular reagents still exist. As an alternative diagnostic test, we present urine analysis through flow-injection-tandem mass spectrometry (FIA-MS/MS) as a powerful approach for COVID-19 diagnosis, targeting the detection of amino acids and acylcarnitines. We adapted a method that is widely used for newborn screening tests on dried blood for urine samples in order to detect metabolites related to COVID-19 infection. We analyzed samples from 246 volunteers with diag
SUBMITTER: Moura AV
PROVIDER: S-EPMC9697918 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA